From concept to indication: Neoadjuvant immunotherapy for operable lung cancer Published 2022-05-27 Download video MP4 360p Recommendations 08:42 IMMUNOTHERAPY: The Path to a Cancer Cure (For Clinicians) 05:11 Playing musical instruments in the MRI - the brain on music 49:17 Alex Tothill-Brown Was Given a Low Chance of Being Cured 10 Years Ago - It Takes Balls 27:03 McGill Talks Episode 6 Marijuana 1:17:03 Comprehensive, Lifelong, Expeditious Aortic Care at the Cutting Edge 20:06 Bladder Cancer: Basics of Diagnosis, Workup, Pathology, and Treatment 13:10 CAR T Cells: Beating Cancer with the Immune System 48:41 McGill Cares: Understanding Vascular Dementia 21:25 Cannabis in Canada - Dr. Mark A Ware, MBBS MSc 1:20:39 HyenaDNA: Long-Range Genomic Sequence Modeling at Single Nucleotide Resolution | Eric Nguyen 2:05:29 3MT| MT180 Competition Final 2024 17:04 Gradients of Brain Organisation - Session 1: Ye Tian, University of Melbourne, Australia 20:22 Living Low Grade, Ben Leske Heaney - Brain Cancer Action Week 2016 56:24 Aviation Safety Management - Kathy Fox of the TSB at McGill University 08:01 What Happens To Your Body When You Take Ketamine 1:01:26 AlphaFold2, OpenFold, Protein Language Models and Beyond | Nazim Bouatta 33:43 JD Heylman’s Sons Were Old Enough to Know He Was Facing Testicular Cancer - It Takes Balls 1:25:49 Cultural Affordances (Samuel Veissière), 2018 FPR-McGill Social & Cultural Neuroscience Workshop 52:17 Endoscopic Sleeve Gastroplasty: Ready for Prime Time! 14:06 How I discovered I had a deadly Brain Tumor: Signs, Symptoms, Surgery, Chemo, Diagnosis, Prognosis Similar videos 48:44 Neoadjuvant, Adjuvant, or Both: Individualized Perioperative Immunotherapy in Resectable NSCLC 1:31:16 Pathologic Response After Neoadjuvant Immunotherapy: Facilitating Progress in Early-Stage Cancers 05:04 Pre-Operative/Neoadjuvant Therapy: Rationale and Indications 06:20 Response and safety profile of neoadjuvant nivolumab for resectable lung cancer 36:55 Immunotherapy in Lung Cancer: Rationale, Evidence, and Implications for the Multidisciplinary Team 59:24 Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer 1:29:06 Leveraging Neoadjuvant and Adjuvant Immunotherapy to Improve Outcomes in Early-Stage Cancers 1:11:16 Immunotherapy as a Game-Changer in Multimodal Management of Lung Cancer 1:05:29 Can the Addition of Immunotherapy to Multimodal Management of Stage I-III NSCLC Improve Outcomes? 2:08:23 FDA-MRA Approaches to Neoadjuvant Treatment in Melanoma: Keynote Lecture & Session 1 1:44:45 Gaining an Advantage Over NSCLC: How to Achieve the Greatest Benefit With Immunotherapy 48:15 Immunotherapy for Lung Cancer: PD-1 and Beyond, with Naiyer Rizvi 06:40 Studies in Oligometastatic NSCLC: Current Data and Definitions - Lung Cancer OncTalk 2022 1:39:44 Advances in the management of Thoracic Malignancies 3 Sep 2021 day 1 part 1 1:37:34 Drs. Schalper, Riess & Wainberg discuss #Immunotherapy #Biomarkers #USCAP22 https://bit.ly/3IYowvD 1:06:01 Drs. Altorki & Spicer discuss immunotherapy advances in stage I-III NSCLC: https://bit.ly/3HVzzoZ 1:40:44 2021 Cancer Symposium: Multidisciplinary Care for Lung Cancer 36:18 Cell Therapy in the Treatment of Solid Tumors More results